Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk Factors of Polyomavirus Nephropathy in Renal Transplant
NCT00160966Phase 4Completed
- Sponsor
- Justus Liebig University Giessen
- Start
- Sep 2004
- Primary completion
- Mar 2010
- Modality
- Peptides, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine, tacrolimus, everolimus in kidney transplant rejection, sponsored by Justus Liebig University Giessen. Started Sep 2004; status: completed.
02
Drugs
cyclosporinetacrolimuseverolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00160966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160966.